It is a drug which is a benzodiazepine by-product. Its mechanism of action seems to be quite diverse from that of most benzodiazepine drugs, and it produces nootropic effects in animal experiments.AVE-1625 is really a hugely potent, selective antagonist for your CB1 receptor with Ki values of 0.16-0.forty four nM. Drinabant attained phase IIb medic